CLINICAL_TRIALS
trial_result
· 2019-09-20
Clinical Trial Update: A Study of Rofecoxib in Familial Adenomatous Polyposis (FAP) (0966-205)(TERMINATED) [Phase 4]
Summary
A Phase 4 trial of rofecoxib in familial adenomatous polyposis (Adenomatous Polyposis Coli) was terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Adenomatous Polyposis Coli | Phase 4 | Status: TERMINATED